letrozole has been researched along with Chemical and Drug Induced Liver Injury in 9 studies
Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 73-year-old female patient with breast cancer with axillary lymph node, adrenal gland and bone metastases was started on ribociclib letrozole and denosumab treatment." | 8.31 | Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab. ( Aktürk Esen, S; Bayram, D; Köş, FT; Uçar, G, 2023) |
| "A consecutive cohort of ER( +)/HER2( -) advanced breast cancer patients who received palbociclib between 2017 and 2018 was analyzed." | 7.96 | Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer. ( Cho, YU; Ham, A; Kim, GM; Kim, JH; Kim, JY; Kim, MH; Kim, SI; Park, BW; Park, HS; Park, S; Sohn, J, 2020) |
| "A 73-year-old female patient with breast cancer with axillary lymph node, adrenal gland and bone metastases was started on ribociclib letrozole and denosumab treatment." | 4.31 | Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab. ( Aktürk Esen, S; Bayram, D; Köş, FT; Uçar, G, 2023) |
| "A consecutive cohort of ER( +)/HER2( -) advanced breast cancer patients who received palbociclib between 2017 and 2018 was analyzed." | 3.96 | Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer. ( Cho, YU; Ham, A; Kim, GM; Kim, JH; Kim, JY; Kim, MH; Kim, SI; Park, BW; Park, HS; Park, S; Sohn, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 2 |
| Warner, DJ | 1 |
| Chen, H | 1 |
| Cantin, LD | 1 |
| Kenna, JG | 1 |
| Stahl, S | 1 |
| Walker, CL | 1 |
| Noeske, T | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Chen, M | 1 |
| Suzuki, A | 1 |
| Thakkar, S | 1 |
| Yu, K | 1 |
| Hu, C | 1 |
| Bayram, D | 1 |
| Aktürk Esen, S | 1 |
| Uçar, G | 1 |
| Köş, FT | 1 |
| Meynard, L | 1 |
| Grellety, T | 1 |
| Farhat, F | 1 |
| Tarabaih, M | 1 |
| Kanj, A | 1 |
| Aoun, M | 1 |
| Kattan, J | 1 |
| Assi, T | 1 |
| Awada, A | 1 |
| Ham, A | 1 |
| Kim, MH | 1 |
| Kim, GM | 1 |
| Kim, JH | 1 |
| Kim, JY | 1 |
| Park, HS | 1 |
| Park, S | 1 |
| Cho, YU | 1 |
| Park, BW | 1 |
| Kim, SI | 1 |
| Sohn, J | 1 |
| Aydin, M | 1 |
| Oktar, S | 1 |
| Ozkan, OV | 1 |
| Alçin, E | 1 |
| Oztürk, OH | 1 |
| Nacar, A | 1 |
1 review available for letrozole and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
8 other studies available for letrozole and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemical and Drug Induced Li | 2023 |
CDK 4/6 inhibitor successful rechallenge after limiting hepatic toxicity.
Topics: Alanine Transaminase; Aminopyridines; Aromatase Inhibitors; Aspartate Aminotransferases; Bone Neopla | 2020 |
Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patient.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemical and Drug | 2020 |
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemical and Drug Induced Li | 2020 |
Letrozole induces hepatotoxicity without causing oxidative stress: the protective effect of melatonin.
Topics: Animals; Antioxidants; Aromatase Inhibitors; Chemical and Drug Induced Liver Injury; Female; Letrozo | 2011 |